Viewing Study NCT00710268


Ignite Creation Date: 2025-12-24 @ 5:56 PM
Ignite Modification Date: 2026-01-04 @ 3:43 AM
Study NCT ID: NCT00710268
Status: COMPLETED
Last Update Posted: 2015-01-14
First Post: 2008-06-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Assess Safety & Tolerability of AZD2281 in Combination With Bevacizumab in Patients With Advanced Solid Tumours
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module